Oral Paper Presentation - Oncology Section
2015-08-22 慈濟大學 和敬樓一樓B101講堂
時間主題
09:30 ~ 09:40
Opening Remarks
講者: TUA President,
Prof. Hann-Chorng Kuo,
ISTUA Chairman,
Prof. Yeong-Shiau Pu
09:40 ~ 09:49
Predict pathologic outcome of radical prostatectomy for clinical stage T2b and T2C prostate cancer
講者: Chi-Rei Yang 座長: Chi-Rei Yang,
Tony T. Wu
09:49 ~ 09:58
Favorable outcome of intraoperative radiotherapy to primary site in patients with metastatic prostate cancer suggests benefits of local therapy: retrospective study of long-term outcomes in a single japanese center
講者: Kanda Toshihiro 座長: Chi-Rei Yang,
Tony T. Wu
09:58 ~ 10:07
Weekly-docetaxel chemotherapy for Taiwanese patients with metastatic castrate-resistant prostate cancer
講者: Cheng-Li Kao 座長: Chi-Rei Yang,
Tony T. Wu
10:07 ~ 10:16
Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel risk stratification model in castration-resistant prostate cancer patients treated with docetaxel chemotherap
講者: Yoshihiro Nakagami 座長: Chi-Rei Yang,
Tony T. Wu
10:16 ~ 10:25
Bone mineral density loss on long-term androgen-deprivation therapy (ADT) for the prostate cancer patients in Japan
講者: Yu Ogawa 座長: Chi-Rei Yang,
Tony T. Wu
10:25 ~ 10:34
Characteristics of arsenic-related bladder cancer: a study from nationwide cancer registry database in Taiwan
講者: Jian-Hua Hong 座長: Chi-Rei Yang,
Tony T. Wu
10:34 ~ 10:43
Timing of 1st recurrence affects subsequent clinical outcome in 1st recurrent low grade ta bladder cancer
講者: Hiroaki Kobayashi 座長: Chi-Rei Yang,
Tony T. Wu
10:43 ~ 10:52
Association of hepatitis and renal cell carcinoma: results for longitudinal national health insurance database in Taiwan
講者: Tzu-Hsiang Wu 座長: Chi-Rei Yang,
Tony T. Wu
10:52 ~ 11:01
Treatment-related deterioration of renal function as a biomarker to predict anti-tumor efficacy of sunitinib in patients with metastatic renal cell carcinoma
講者: Hironori Fukuda 座長: Chi-Rei Yang,
Tony T. Wu
11:05 ~ 11:15
Break and Group Photos